Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

June 30, 2008

Conditions
Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

pemetrexed disodium

Trial Locations (20)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

55455

Fairview University Medical Center - University Campus, Minneapolis

55905

Mayo Clinic Cancer Center, Rochester

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

94305

Stanford Cancer Center at Stanford University Medical Center, Stanford

206987

Children's Hospital and Regional Medical Center - Seattle, Seattle

215590

Children's Hospital of Philadelphia, Philadelphia

301496

NCI - Pediatric Oncology Branch, Bethesda

323669

Children's Hospital Los Angeles, Los Angeles

832822

Baylor University Medical Center - Houston, Houston

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Cancer Center, Indianapolis

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

39216-4505

University of Mississippi Medical Center, Jackson

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

97239-3098

Cancer Institute at Oregon Health and Science University, Portland

Unknown

Hospital for Sick Children, Toronto

Hopital Sainte Justine, Montreal

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00070473 - Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter